Please assess the completion status of the following clinical trial:

Trial Title: Effect of Bupivacaine-infused Fibrin Sealant Application on Post-tonsillectomy Pain & Hemorrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. All children aged 1 through age 12 and weighing \>10 kilograms who are scheduled for tonsillectomy or adenotonsillectomy for the following indications by surgical staff included in the IRB submission will be considered for inclusion in the study.~A) Chronic Pharyngitis / Recurrent Tonsillitis B) PAPFA (Periodic Aphthous Ulcers / Pharyngitis / Fevers / Adenopathy) Syndrome C) Upper Aerodigestive Obstruction Symptoms felt to be related to tonsil size. D) Adenotonsillar Hypertrophy (enlarged tonsils and adenoids) E) Obstructive Sleep Apnea (clinical diagnosis or by Polysomnogram \[sleep study\]) F) Chronic/Recurrent Tonsillolithiasis (tonsil stones)~Exclusion Criteria:~1. Undergoing additional surgical procedures within 14 days preceding or following the tonsillectomy or adenotonsillectomy which could affect pain assessment scores.~2. Additional concurrent surgical procedures (other than direct laryngoscopy, bronchoscopy, nasal endoscopy, ear examination under anesthesia, cerumen removal, or myringotomy with ear ventilation tube placement)~2. If decision is made to perform supraglottoplasty for laryngomalacia intraoperatively~3. Tonsillectomy or adenotonsillectomy for concern of malignancy of unknown primary~4. Documented aprotinin allergy~5. Documented amide anesthetic allergy~6. Documented bleeding disorder~7. Documented anticoagulant use~8. Documented chronic pain disorder~9. Documented chronic use of prescription narcotics or methadone~10. Documented history of substance abuse or illicit drug use~11. Documented history of alcoholism or alcohol abuse~12. Gastrostomy/orogastric/nasogastric tube placement/use~13. Planned postoperative ICU placement~14. Refusal to participate~15. Exclusion at judgment of investigator (Language barriers, Ward of Court, etc.)

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 12 Years
- Healthy Volunteers: t

Study Arms:
- Control (Type: NO_INTERVENTION): 44 patients will be randomized to receive no topical treatment to their tonsillectomy (or adenotonsillectomy) wound bed as is the current standard of care at our institution. The wound bed will be treated with instrumentation in the operating room to ensure adequate hemostasis alone.
- Fibrin Sealant Alone (Type: ACTIVE_COMPARATOR): 44 patients will be randomized to receive application of topical fibrin sealant to their tonsillectomy (or adenotonsillectomy) wound bed to assess the pain reduction benefits of fibrin sealant alone. Prior to application of fibrin sealant, the wound bed will be treated with instrumentation in the operating room to ensure adequate hemostasis.
- Bupivacaine-infused Fibrin Sealant (Type: EXPERIMENTAL): 44 patients will be randomized to receive application of topical bupivacaine-infused fibrin sealant to their tonsillectomy (or adenotonsillectomy) wound bed to assess the pain reduction benefits of fibrin sealant alone. Prior to application of fibrin sealant, the wound bed will be treated with instrumentation in the operating room to ensure adequate hemostasis.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: regulatory/approval